UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Compton Wealth Advisory Group LLC

Compton Wealth Advisory Group LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8.3% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 8,374 shares of the healthcare conglomerate’s stock after purchasing an additional 645 shares during the quarter. UnitedHealth Group accounts for 1.4% of Compton Wealth Advisory Group LLC’s investment portfolio, making the stock its 18th biggest holding. Compton Wealth Advisory Group LLC’s holdings in UnitedHealth Group were worth $4,409,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Robbins Farley acquired a new position in shares of UnitedHealth Group in the third quarter worth $25,000. Richelieu Gestion SA acquired a new position in shares of UnitedHealth Group in the fourth quarter worth $26,000. CGC Financial Services LLC raised its holdings in shares of UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares during the last quarter. NewSquare Capital LLC raised its holdings in shares of UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 51 shares during the last quarter. Finally, Strategic Investment Solutions Inc. IL acquired a new position in shares of UnitedHealth Group in the first quarter worth $35,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have recently commented on UNH. Truist Financial reaffirmed a “buy” rating and issued a $610.00 price objective on shares of UnitedHealth Group in a research report on Thursday, November 30th. HSBC reaffirmed a “reduce” rating and issued a $480.00 price objective (down previously from $550.00) on shares of UnitedHealth Group in a research report on Monday, December 18th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 19th. Piper Sandler lowered their price objective on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating for the company in a research report on Wednesday, January 17th. Finally, Bank of America reissued a “buy” rating and set a $675.00 price target on shares of UnitedHealth Group in a research report on Thursday, March 7th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $579.33.

UnitedHealth Group Stock Up 0.3 %

Shares of UNH stock traded up $1.60 during trading hours on Friday, reaching $494.70. The company had a trading volume of 3,820,008 shares, compared to its average volume of 4,274,309. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79. UnitedHealth Group Incorporated has a twelve month low of $445.68 and a twelve month high of $554.70. The company has a market capitalization of $456.08 billion, a P/E ratio of 20.75, a price-to-earnings-growth ratio of 1.34 and a beta of 0.54. The stock’s fifty day simple moving average is $502.66 and its 200 day simple moving average is $518.44.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. The firm had revenue of $94.43 billion during the quarter, compared to the consensus estimate of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. UnitedHealth Group’s revenue for the quarter was up 14.1% on a year-over-year basis. During the same quarter in the prior year, the business posted $5.34 earnings per share. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.82 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were given a $1.88 dividend. This represents a $7.52 annualized dividend and a yield of 1.52%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 31.54%.

Insider Activity

In other news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.